NTLA
Intellia Therapeutics, Inc.
Set alert
12.47 USD -0.76 -5.74%
12.04 Day range 13.13
8.04 52-week range 17.84
- YTD
- +38.71%
- 1 year
- +1.63%
- Open
- 12.82
- Prev close
- 13.23
- Mkt cap
- 1.75B
- Vol
- 4.09M
- Avg vol
- 4.36M
- EPS
- -3.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.04
- High
- 13.13
- Forward P/E
- -4.86
- Beta
- 1.80
- Short ratio
- 7.63
- Inst. own
- 100.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 12.23
- 200-d avg
- 13.08
- 1y target
- 23.11
1Y chart
Closing price and volume
Compare NTLA
Chart and line up NTLA against other symbols or a saved comparison set.
- NTLA Intellia Therapeutics, Inc.
12.47
-0.76 -5.74%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | NTLA | SPY | QQQ |
|---|---|---|---|
| Last price | 12.47 | 755.72 | 690.49 |
| Change | -0.76 | -13.64 | -24.85 |
| Change % | -5.74% | -1.77% | -3.47% |
| Open | 12.82 | 761.38 | 697.13 |
| Day high | 13.13 | 761.46 | 698.63 |
| Day low | 12.04 | 750.36 | 683.45 |
| Previous close | 13.23 | 769.36 | 715.34 |
| Volume | 4.09M | 77.70M | 85.24M |
| Average volume | 4.36M | 41.22M | 34.57M |
| Market cap | 1.75B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -3.35 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 17.84 | 779.09 | 759.66 |
| 52-week low | 8.04 | 631.97 | 558.28 |
| 1-week return | +11.24% | -0.559233% | -1.97% |
| 1-month return | +3.40% | -0.906075% | -6.66% |
| 3-month return | +12.44% | +1.89% | +1.02% |
| 6-month return | -7.49% | +5.16% | +3.41% |
| Year-to-date return | +38.71% | +10.82% | +12.40% |
| 1-year return | +1.63% | +11.16% | +10.29% |
| 2-year return | -12.31% | +32.90% | +42.71% |
| 50-day moving average | 12.23 | 767.63 | 725.41 |
| 200-day moving average | 13.08 | 728.53 | 679.17 |
| Target price | 23.11 | — | — |
| Beta | 1.80 | 0.00 | 0.00 |
| Short ratio | 7.63 | — | — |
| Institutional ownership | 100.56% | — | — |